| Rolando R Lopez, PA | |
|
24 Hospital Ave, Danbury, CT 06810 | |
| (203) 739-7000 | |
| Not Available |
| Full Name | Rolando R Lopez |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 36 Years |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558396408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 975 (Connecticut) | Secondary |
| 363A00000X | Physician Assistant | 000975 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
Kansas has updated its roster of disabled residents who have requested state-funded, in-home medical care and is now better equipped to provide that care more quickly and efficiently, officials in the governor's office said Monday. The waiting list was cut by more than a third, from 3,423 to 2,197 people, after a company hired by the state spent the last few months trying to reach out to those on the lists, Lt. Gov. Jeff Colyer and Aging and Disability Services Secretary Shawn Sullivan said.
A new study describes a small molecule referred to as RG10 that may have potent antiviral activity against SARS-CoV-2 in human cells.
Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.
Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the Duke University Comprehensive Cancer Center.
Today GenVec, Inc. announced that it will implement a one for ten reverse stock split of the Company's outstanding shares of common stock. The reverse stock split will be effective with respect to stockholders of record at the close of business on Monday, April 18, 2011, and trading of the Company's common stock on the NASDAQ Capital Market will begin on a split-adjusted basis at the opening of trading on Tuesday, April 19, 2011.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rolando R Lopez, PA 39 Hospital Ave, Danbury, CT 06810-6027 Ph: (203) 744-9700 | Rolando R Lopez, PA 24 Hospital Ave, Danbury, CT 06810 Ph: (203) 739-7000 |
News Archive
Kansas has updated its roster of disabled residents who have requested state-funded, in-home medical care and is now better equipped to provide that care more quickly and efficiently, officials in the governor's office said Monday. The waiting list was cut by more than a third, from 3,423 to 2,197 people, after a company hired by the state spent the last few months trying to reach out to those on the lists, Lt. Gov. Jeff Colyer and Aging and Disability Services Secretary Shawn Sullivan said.
A new study describes a small molecule referred to as RG10 that may have potent antiviral activity against SARS-CoV-2 in human cells.
Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.
Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the Duke University Comprehensive Cancer Center.
Today GenVec, Inc. announced that it will implement a one for ten reverse stock split of the Company's outstanding shares of common stock. The reverse stock split will be effective with respect to stockholders of record at the close of business on Monday, April 18, 2011, and trading of the Company's common stock on the NASDAQ Capital Market will begin on a split-adjusted basis at the opening of trading on Tuesday, April 19, 2011.
› Verified 1 days ago